RANKINGS

POPULAR STOCKS

Samsung Biologics Co.,Ltd.

KSE:207940.KS

Location

South Korea

Market Cap

USD 52.50 B

Share Price

USD 737.62

Avg Daily Volume

76,833

Change (1 day)

2.27%

Change (1 year)

38.10%

Change (YTD)

14.98%

Samsung Biologics Co.,Ltd. Common Stock Issued for the year ending December 31, 2024: USD 0.00

Samsung Biologics Co.,Ltd. Common Stock Issued is USD 0.00 for the year ending December 31, 2024. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • Samsung Biologics Co.,Ltd. Common Stock Issued for the year ending December 31, 2023 was USD 0.00, a -100.00% change year over year.
  • Samsung Biologics Co.,Ltd. Common Stock Issued for the year ending December 31, 2022 was USD 2.53 B.
  • Samsung Biologics Co.,Ltd. Common Stock Issued for the year ending December 31, 2021 was USD 0.00.
  • Samsung Biologics Co.,Ltd. Common Stock Issued for the year ending December 31, 2020 was USD 0.00.
Key data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow
Market news
KSE: 207940.KS

Samsung Biologics Co.,Ltd.

CEO Mr. John Chongbo Rim
IPO Date Nov. 11, 2016
Location South Korea
Headquarters 300, Songdo Bio-daero
Employees 4,770
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
💳 Credit Cards & Payments
🏥 Hospitals & Clinics
💰 Venture Capital
Description

Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Similar companies

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

SHL.DE

Siemens Healthineers AG

USD 53.26

0.96%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

BIM.PA

bioMérieux S.A.

USD 138.60

1.42%

BAX

Baxter International Inc.

USD 29.99

0.64%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 1.97

-0.51%

CTEC.L

ConvaTec Group Plc

USD 3.81

1.16%

GMED

Globus Medical, Inc.

USD 57.87

0.87%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.72

-2.62%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.10

-0.68%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.61

-0.28%

688617.SS

APT Medical Inc.

USD 38.32

1.54%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.67

0.40%

TMDX

TransMedics Group, Inc.

USD 123.56

-0.36%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.82

0.10%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.94

-0.04%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 12.79

-1.57%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.46

0.30%

QDEL

QuidelOrtho Corporation

USD 28.03

-1.06%

NVCR

NovoCure Limited

USD 16.69

-0.66%

0853.HK

MicroPort Scientific Corporation

USD 1.00

-0.13%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.76

-0.53%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.51

0.67%

NOVO-B.CO

Novo Nordisk A/S

USD 73.32

-2.33%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

ABT

Abbott Laboratories

USD 132.99

0.44%

NOVN.SW

Novartis AG

USD 115.96

-0.50%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

AMGN

Amgen Inc.

USD 289.33

-0.10%

BSX

Boston Scientific Corporation

USD 101.30

-0.07%

TMO

Thermo Fisher Scientific Inc.

USD 397.88

1.35%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

VRTX

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK.L

GSK plc

USD 18.89

-2.25%

CSL.AX

CSL Limited

USD 154.82

0.08%

COR

Cencora, Inc.

USD 293.66

-1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

BDX

Becton, Dickinson and Company

USD 168.42

-0.10%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB.BR

UCB SA

USD 181.46

0.14%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

StockViz Staff

June 24, 2025

Any question? Send us an email